Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent?

Polyguanine sequences fold into G-quadruplex structures in the presence of monovalent cations. It is accepted that the telomeric DNA region consists of G-quadruplex structure. There are reports that potential G-quadruplex forming motifs are also present in the promoter region of some proto-oncogenes such as c-myc, c-kit, KRAS, etc. Small molecules with the potential to stabilize the telomeric DNA quadruplex have emerged as potential anticancer agents. We have studied the interaction of ellipticine, a putative anticancer agent from a plant source, with a human telomeric DNA sequence (H24). Spectroscopic and calorimetric studies indicate that the association of ellipticine with H24 is an entropically driven phenomenon with a 2:3 (H24:ellipticine) stoichiometry. Though ellipticine binding does not induce any major structural perturbation in H24, the association leads to formation of a complex with enhanced thermal stability. An assay with the telomerase repeat amplification protocol shows that ellipticine inhibits telomerase activity in MDAMB-231 breast cancer cell line extracts. This is the first report of the quadruplex binding ability of ellipticine. Using the results, we propose that along with DNA intercalation and/or topoisomerase II inhibition, interaction with the telomeric DNA region and the resultant inhibition of telomerase activity might be an additional mode of action for its anticancer property.

[1]  V. Sharma,et al.  Effect of Ionic Strength on Porphyrin Drugs Interaction with Quadruplex DNA Formed by the Promoter Region of C-myc and Bcl 2 Oncogenes , 2014 .

[2]  D. Dasgupta,et al.  Molecular basis of recognition of quadruplexes human telomere and c-myc promoter by the putative anticancer agent sanguinarine. , 2013, Biochimica et biophysica acta.

[3]  Dik‐Lung Ma,et al.  Aminoglycosylation Can Enhance the G-Quadruplex Binding Activity of Epigallocatechin , 2013, PloS one.

[4]  Paola Gratteri,et al.  The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1 , 2012, Nucleic acids research.

[5]  Chunying Wei,et al.  The interactions of phenanthroline compounds with DNAs: preferential binding to telomeric quadruplex over duplex. , 2013, International journal of biological macromolecules.

[6]  M. F. Sassano,et al.  Identification of G-Quadruplex Inducers Usinga Simple, Inexpensiveand Rapid High Throughput Assay, and TheirInhibition of Human Telomerase , 2012, The open medicinal chemistry journal.

[7]  W. Han,et al.  Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region. , 2012, Biochemical pharmacology.

[8]  Hyun-Ju Park,et al.  G-quadruplex binding ligands: from naturally occurring to rationally designed molecules. , 2012, Current pharmaceutical design.

[9]  Jean-Louis Mergny,et al.  Interaction of human telomeric DNA with N-methyl mesoporphyrin IX , 2012, Nucleic acids research.

[10]  V. Dhamodharan,et al.  Selective G-quadruplex DNA stabilizing agents based on bisquinolinium and bispyridinium derivatives of 1,8-naphthyridine. , 2012, The Journal of organic chemistry.

[11]  U. Bierbach,et al.  Interactions of a platinum-modified perylene derivative with the human telomeric G-quadruplex. , 2011, The journal of physical chemistry. B.

[12]  M. J. Swamy,et al.  Isothermal Titration Calorimetric Studies on the Interaction of the Major Bovine Seminal Plasma Protein, PDC-109 with Phospholipid Membranes , 2011, PloS one.

[13]  G. Parkinson,et al.  A structural analysis of G-quadruplex/ligand interactions. , 2011, Biochimie.

[14]  R. Kizek,et al.  Ellipticine cytotoxicity to cancer cell lines — a comparative study , 2011, Interdisciplinary toxicology.

[15]  D. Arya,et al.  Synthesis and spectroscopic studies of the aminoglycoside (neomycin)--perylene conjugate binding to human telomeric DNA. , 2011, Biochemistry.

[16]  G. Basu,et al.  Human telomere d[(TTAGGG)4] undergoes a conformational transition to the Na+-form upon binding with sanguinarine in presence of K+. , 2011, Biochemical and biophysical research communications.

[17]  P. Majumder,et al.  Mechanism of interaction of small transcription inhibitors with DNA in the context of chromatin and telomere. , 2010, Biochimica et biophysica acta.

[18]  Chunying Wei,et al.  Spectroscopic study on the binding of porphyrins to (G(4)T(4)G(4))4 parallel G-quadruplex. , 2010, Biophysical chemistry.

[19]  Danzhou Yang,et al.  Structural insights into G-quadruplexes: towards new anticancer drugs. , 2010, Future medicinal chemistry.

[20]  E. LaVoie,et al.  Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. , 2008, Biochimie.

[21]  A. Phan,et al.  Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.

[22]  Stephen Neidle,et al.  Mechanism of acridine-based telomerase inhibition and telomere shortening. , 2007, Biochemical pharmacology.

[23]  Kwok‐yin Wong,et al.  9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. , 2007, Bioorganic & medicinal chemistry.

[24]  A. R. Srinivasan,et al.  Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA , 2007, Nucleic acids research.

[25]  J. Chaires,et al.  Biophysical characterization of the human telomeric (TTAGGG)4 repeat in a potassium solution. , 2007, Biochemistry.

[26]  A. Phan,et al.  Different loop arrangements of intramolecular human telomeric (3+1) G-quadruplexes in K+ solution , 2006, Nucleic acids research.

[27]  J. Duhamel,et al.  Solvent effect on the photophysical properties of the anticancer agent ellipticine. , 2006, The journal of physical chemistry. A.

[28]  Dinshaw J. Patel,et al.  Structure of the human telomere in K+ solution: an intramolecular (3 + 1) G-quadruplex scaffold. , 2006, Journal of the American Chemical Society.

[29]  Jingli Yuan,et al.  A spectroscopic study on the interactions of porphyrin with G-quadruplex DNAs. , 2006, Biochemistry.

[30]  S. Neidle,et al.  Natural and synthetic G-quadruplex interactive berberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.

[31]  Lin Ma,et al.  Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. , 2005, Journal of medicinal chemistry.

[32]  W. Wilson,et al.  Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. , 2005, Journal of the American Chemical Society.

[33]  Vijay Gokhale,et al.  Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. , 2005, Journal of the American Chemical Society.

[34]  D. Bearss,et al.  Telomeres and telomerases as drug targets. , 2002, Current opinion in pharmacology.

[35]  K. P. Murphy,et al.  van't Hoff and calorimetric enthalpies II: effects of linked equilibria. , 2002, Biochemistry.

[36]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Mergny,et al.  Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. , 2001, Nucleic acids research.

[38]  D. Bhattacharyya,et al.  Structural basis of DNA recognition by anticancer antibiotics, chromomycin A(3), and mithramycin: roles of minor groove width and ligand flexibility. , 2000, Biopolymers.

[39]  P. Bolton,et al.  Porphyrins can catalyze the interconversion of DNA quadruplex structural types. , 1999, Anti-cancer drug design.

[40]  R. Dahse,et al.  Telomeres and telomerase: biological and clinical importance. , 1997, Clinical chemistry.

[41]  B. Kragelund,et al.  Thermodynamics of ligand binding to acyl-coenzyme A binding protein studied by titration calorimetry. , 1996, Biochemistry.

[42]  N. Osheroff,et al.  Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA. , 1995, The Journal of Biological Chemistry.

[43]  M. Singh,et al.  High-field NMR and restrained molecular modeling studies on a DNA heteroduplex containing a modified apurinic abasic site in the form of covalently linked 9-aminoellipticine. , 1994, Biochemistry.

[44]  C. MacKenzie,et al.  Probing the combining site of an anti-carbohydrate antibody by saturation-mutagenesis: role of the heavy-chain CDR3 residues. , 1993, Biochemistry.

[45]  C. Paoletti,et al.  Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship. , 1992, Molecular pharmacology.

[46]  D. Bundle,et al.  Thermodynamics of oligosaccharide binding to a monoclonal antibody specific for a Salmonella O-antigen point to hydrophobic interactions in the binding site. , 1992, The Journal of biological chemistry.

[47]  P. Aich,et al.  Role of magnesium ion in the interaction between chromomycin A3 and DNA: binding of chromomycin A3-Mg2+ complexes with DNA. , 1992, Biochemistry.

[48]  G. Fasman,et al.  Convex constraint analysis: a natural deconvolution of circular dichroism curves of proteins. , 1991, Protein engineering.

[49]  P. Privalov,et al.  Heat capacity of proteins. I. Partial molar heat capacity of individual amino acid residues in aqueous solution: hydration effect. , 1990, Journal of molecular biology.

[50]  R. S. Spolar,et al.  Hydrophobic effect in protein folding and other noncovalent processes involving proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Auclair.  Multimodal action of antitumor agents on DNA: the ellipticine series. , 1987, Archives of biochemistry and biophysics.

[52]  R. L. Baldwin,et al.  Temperature dependence of the hydrophobic interaction in protein folding. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Y. Huang.  Determination of binding stoichiometry by the continuous variation method: the Job plot. , 1982, Methods in enzymology.

[54]  J M Sturtevant,et al.  Heat capacity and entropy changes in processes involving proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Lepecq,et al.  A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. , 1967, Journal of molecular biology.